A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
Clinical trial NCT04882878 · COMPLETED
Trial details
- NCT number
- NCT04882878
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-20
- Primary completion
- 2024-04-30
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.